SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Faeth Therapeutics Reports Third-Quarter 2026 Results and Operational Updates

Faeth Therapeutics announced financial results for the quarter ended September 30, 2026, and highlighted recent corporate accomplishments and 2026 milestones.

FTH
SquawkNews Desk

Faeth Therapeutics (NASDAQ:FTH), a clinical-stage oncology company developing multi-node therapies for cancer patients, including its lead program PIKTOR, today announced financial results for the quarter ended September 30, 2026, and highlighted recent corporate accomplishments and 2026 milestones…

Related stories

Fusemachines Reports Q3 2026 Revenue Growth and Operating Loss Improvements Fusemachines announced revenue growth and improved operating losses in its Q3 2026 results. M impact | EQUITY | Nov 03, 2026, 01:37 PM UTC J.M. Smucker to Report Second-Quarter Earnings The company says it will release its second-quarter earnings. M impact | EQUITY | Nov 03, 2026, 01:36 PM UTC Lazarus AI Raises $43 Million Lazarus AI raised $43 million to advance independent AI. M impact | EQUITY | Nov 03, 2026, 01:34 PM UTC Willis Lease Finance Reports Record Q3 Revenue of $246.3 Million Third-quarter 2026 revenue rose 34.3% year over year to $246.3 million. Net income attributable to common shareholders was $10.2 million, operating income was $11.5 million, dilute M impact | EQUITY | Nov 03, 2026, 01:34 PM UTC Ace Pillar Reports Third-Quarter Net Profit of NT$101.7 Million Ace Pillar reported third-quarter net profit of NT$101.7 million, compared with NT$52.7 million a year earlier. Revenue was NT$1,434,436,000 versus NT$1,089,114,000, and pretax pro M impact | EQUITY | Nov 03, 2026, 01:33 PM UTC Liquidia Sets Nov. 10 Date to Report Third-Quarter 2026 Results Liquidia Corporation said it will report its third-quarter 2026 financial results on Nov. 10, 2026. M impact | EQUITY | Nov 03, 2026, 01:32 PM UTC